Vaccines and Therapeutic Developments
A section of Pathogens (ISSN 2076-0817).
Section Information
The Covid-19 pandemic has dramatically exposed the shortcomings of our health and research systems when confronted with an unexpected new challenge. Vaccine development and new therapeutic strategies to fight old, re-emerging, and new infectious diseases represent the focus of this Section of Pathogens, with the ultimate aim to contribute to global health improvement. Human and veterinary vaccine and therapeutic advancements with regard to basic and clinical aspects for bacterial, viral, fungal and parasitic diseases will be considered. Contributions delineating survival and fatal outcomes, and correlates of protection are particularly encouraged. Novel delivery approaches, carrier/adjuvant systems and immunomodulatory therapy are also welcome.
Main topics include (but are not limited to):
Basic immunology and animal models
Vaccine design and technology
Therapy and vaccine delivery, safety and efficacy assessment
Human and veterinary vaccines for bacterial, fungal, viral, parasitic diseases
Immunotherapeutic developments
New approaches to therapy, novel druggable candidates and strategies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Malaria: Current Opportunities in Therapeutics and Vaccines (Deadline: 30 October 2023)
- Advanced Research on Vaccine Development for Infectious Diseases (Deadline: 31 October 2023)
- Advances in Treatment of Biofilm Infections (Deadline: 10 November 2023)
- Influenza Virus Pathogenesis and Vaccines (Deadline: 15 November 2023)
- SARS-CoV-2 Variants Research and Vaccines (Deadline: 20 November 2023)
- Chlamydia trachomatis: Innate Immunity, Vaccines and Behaviour (Deadline: 30 November 2023)
- The Multifaceted Parvoviridae Family: From Pathogens to Therapeutics (Deadline: 1 December 2023)
- Impact of Bacterial and Viral Pathogens on Sepsis Prevalence and Outcome (Deadline: 15 December 2023)
- Oncopathogens (Deadline: 31 December 2023)
- Experimental and Spontaneous Animal Models to Study Pathogenesis and New Therapeutic Approaches to Human Viral Diseases (Deadline: 31 December 2023)
- Current Vaccine Strategies and Novel Vaccine Development for Bluetongue Virus and Other Orbiviruses (Deadline: 31 December 2023)
- Host-Pathogen Interactions and Monoclonal Antibody Therapeutics (Deadline: 31 December 2023)
- Schistosomiasis: From Immunopathology to Vaccines (Deadline: 31 January 2024)
- Veterinary Parasitic Diseases: Advancements in Diagnostics, Therapeutics, and Vaccines (Deadline: 31 January 2024)
- SARS-CoV-2 Vaccines and Vaccine-Induced Immunity (Deadline: 29 February 2024)
- Biomarkers for Human and Veterinary Infectious Diseases (Deadline: 25 March 2024)
- Human Papillomavirus Infection and Vaccine Research (Deadline: 31 March 2024)
Topical Collection
Following topical collection within this section is currently open for submissions: